High bone density due to a mutation in LDL-receptor-related protein 5.
暂无分享,去创建一个
Richard P Lifton | R. Lifton | A. Farhi | Dianqing Wu | J. Mao | L. Boyden | Dianqing Wu | Lynn M Boyden | Karl Insogna | Anita Farhi | Junhao Mao | K. Insogna | Joseph Belsky | Lyle Mitzner | Mary A Mitnick | M. Mitnick | J. Belsky | L. Mitzner | J. Mao | Anita Farhi
[1] D. Weaver,et al. Bone mineral density and laboratory evaluation of a type II autosomal dominant osteopetrosis carrier. , 1999, American journal of medical genetics.
[2] Susan R. Johnson,et al. Osteoporosis prevention, diagnosis, and therapy. , 2001, JAMA.
[3] M. Gelman. Autosomal dominant osteosclerosis. , 1977, Radiology.
[4] M. Bia,et al. Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] D. Weaver,et al. Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity. , 1998, Biochemical and biophysical research communications.
[6] Doris Wedlich,et al. The Wnt/Wg Signal Transducer β-Catenin Controls Fibronectin Expression , 1999, Molecular and Cellular Biology.
[7] L. Peltonen,et al. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. , 1996, American journal of human genetics.
[8] J. Ladenson,et al. Creatine kinase brain isoenzyme (BB‐CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] Daniel L. Koller,et al. Linkage of a QTL Contributing to Normal Variation in Bone Mineral Density to Chromosome 11q12–13 , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] E. Haan,et al. Neurological involvement in Worth type endosteal hyperostosis: report of a family. , 1994, American journal of medical genetics.
[11] Y. Omori,et al. Idiopathic osteosclerosis. A report of 6 related cases. , 1968, Radiology.
[12] J. Kerstetter,et al. Increased circulating concentrations of parathyroid hormone in healthy, young women consuming a protein-restricted diet. , 1997, The American journal of clinical nutrition.
[13] V. Sheffield,et al. Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation. , 1998, Human molecular genetics.
[14] H. Verhaar,et al. Comparison of the action of 17 beta-estradiol and progestins with insulin-like growth factors-I/-II and transforming growth factor-beta 1 on the growth of normal adult human bone-forming cells. , 1995, Maturitas.
[15] R. Owen. Van Buchem's disease (hyperostosis corticalis generalisata) , 1976, The British journal of radiology.
[16] M. Järvinen,et al. Epidemiology of Osteoporotic Pelvic Fractures in Elderly People in Finland: Sharp Increase in 1970–1997 and Alarming Projections for the New Millennium , 2000, Osteoporosis International.
[17] K. Insogna,et al. Parathyroid hormone increases circulating levels of fibronectin in vivo: modulating effect of ovariectomy. , 1997, Endocrinology.
[18] Worth Hm,et al. Hyperostosis corticalis generalisata congenita. , 1966 .
[19] Stuart A. Aaronson,et al. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow , 2001, Nature Cell Biology.
[20] R. Gorlin,et al. Autosomal dominant osteosclerosis. , 1977, Radiology.
[21] Mark L. Johnson,et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.
[22] S. Cummings,et al. Epidemiology and predictors of fractures associated with osteoporosis. , 1997, The American journal of medicine.
[23] S. Teitelbaum,et al. Bone resorption by osteoclasts. , 2000, Science.
[24] E. Canalis,et al. Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone , 1991, Molecular and cellular biology.
[25] Hyesung Jeon,et al. Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair , 2001, Nature Structural Biology.
[26] Mark L. Johnson,et al. Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13) , 1997, American journal of human genetics.
[27] R. Marcus,et al. Peak Bone Mass , 2000, Osteoporosis International.
[28] J. Pérez-Vicente,et al. Autosomal dominant endosteal hyperostosis , 1987, Clinical genetics.
[29] K. Insogna,et al. Estrogen modulates parathyroid hormone-induced fibronectin production in human and rat osteoblast-like cells. , 1994, Endocrinology.
[30] T. Springer,et al. An extracellular beta-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components. , 1998, Journal of molecular biology.
[31] A. Geiser,et al. Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene. , 1998, Bone.
[32] C. Damsky,et al. Fibronectin is a survival factor for differentiated osteoblasts. , 1998, Journal of cell science.
[33] Miikka Vikkula,et al. LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.
[34] W M O'Fallon,et al. Determinants of Reduced Survival Following Hip Fractures in Men , 1995, Clinical orthopaedics and related research.
[35] Michael Kühl,et al. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6 , 2001, Current Biology.
[36] S. Aota,et al. Fibronectin regulates calvarial osteoblast differentiation. , 1996, Journal of cell science.
[37] J Mao,et al. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. , 2001, Molecular cell.